Sign In
NewsRadar

KREATECH Diagnostics (acquired by Leica)

Kreatech Diagnostics is a molecular diagnostics company focused on the development and commercialization of DNA probes and nucleic acid labeling technologies that are utilized for diagnostics and research applications in the life sciences and healthcare industry, specifically cytogenetics, molecular pathology, and microarrays.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Vlierweg 20
Amsterdam 1032 LG
Netherlands
+31 20 691 91 81
+ 31 20 630 42 47
http://www.kreatech.com
Harald Berninger
+31 20 691 91 81

Company Facts
Founded:Jan 1990
Founders:Hendrik-Jan Houthoff, Herman Volkers
CEO:Kees Moonen
CTO or technical lead:Herman Volkers
CFO or finance director:
Head of Sales:Harald Berninger
Head of Marketing:Harald Berninger

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Diagnostics
Employees:50
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:No

Non-executive Board Members

Key Customers

Key Business Partners

  • Qiagen
  • PerkinElmer
  • Sigma
  • QBiogene
  • Roche

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    21,136
    Tech investments
    From our Online Data Service
    13,654
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Feb 8N/AWireless applications
    Feb 5€0.1MInternet services
    Feb 4€0.5MMedical devices
    Feb 4€5.0MMedical devices
    Feb 3€22.0MBiopharmaceuticals
    Feb 3€1.4MOther Biotechnology & Healthcare
    Feb 2€0.2MWireless applications

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    Feb 2
    Spotcap
    online lending platform spotcap raises eur 31.5m in funding

    Feb 2
    Mission Therapeutics
    mission therapeutics raises 60 million to progress development of ...

    Feb 2
    Watchmaster
    watchmaster snags $8 mln series b

    Jan 21
    Endeit Capital
    endeit capital holds 125 million final close for new fund

    Jan 20
    ysura GmbH
    ysura lands top talent joern jackowski and enters otc market





    About usContact usLegal Information
    Copyright 1999-2016
    Emerging Technology Research Europe Inc. All rights reserved.